<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="39690" end="39701" sStart="-1" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="24 h after transfection, the cells were &lt;b&gt;transferred&lt;/b&gt; to 10-cm plates and grown for another 24 h." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="39690" end="39701" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="24 h after transfection, the cells were &lt;b&gt;transferred&lt;/b&gt; to 10-cm plates and grown for another 24 h." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="39690" end="39701" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="24 h after transfection, the cells were &lt;b&gt;transferred&lt;/b&gt; to 10-cm plates and grown for another 24 h." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="40197" end="40208" sStart="null" offset="0" sid="null" wn="9" wnkey="transfer%2:30:00::" text="Fractions were resolved by 12% SDS-PAGE, &lt;b&gt;transferred&lt;/b&gt; onto PVDF-Plus (Micron Separations, Inc) and probed with EE monoclonal antibody." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-12.anc" start="16690" end="16696" sStart="null" offset="121" sid="r11.strong.j.0342" wn="2" wnkey="strong%5:00:00:intense:00" text="s? i2 shows a dramatic change in localization when co-expressed with ?? (Figure 8D), displaying strong PM staining." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2121-3-12.anc" start="31117" end="31123" sStart="null" offset="0" sid="null" wn="2" wnkey="show%2:31:00::" text="A specific combination of ? and ? subtypes may play such a role; however, one thorough study &lt;b&gt;showed&lt;/b&gt; a lack of ?? on Golgi membranes of exocrine pancreatic cells even though a variety of G? were readily detected in the Golgi [ 33 ] . Other proteins that may specifically promote the intracellular targeting of G? have not been identified." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-12.anc" start="15930" end="15936" sStart="null" offset="133" sid="r11.severe.j.0233" wn="1" wnkey="severe%5:00:00:intense:00" text="It seems likely that the C-terminal disruption of s? i2 (replacing the 24 C-terminal amino acids) is a more severe disruption than the A327S substitution." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="23785" end="23790" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" text="A recent study identified a number of ?5 helix residues in ? t that when changed to alanines increased &lt;b&gt;rates&lt;/b&gt; of guanine-nucleotide exchange ( i.e., decreased affinity for guanine-nucleotides) [ 5 ] . Individual mutation of amino acids in ? t , cognate to T330, N332, V333, F337 in ? i2 (Figure 1), increased nucleotide exchange &lt;b&gt;rates&lt;/b&gt; [ 5 ] . Two of these critical amino acids, N332 and V333 in ? i2 , are in fact the first two amino acids that are replaced by the novel splicing in s? i2 (Figure 1)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="23785" end="23790" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" text="A recent study identified a number of ?5 helix residues in ? t that when changed to alanines increased &lt;b&gt;rates&lt;/b&gt; of guanine-nucleotide exchange ( i.e., decreased affinity for guanine-nucleotides) [ 5 ] . Individual mutation of amino acids in ? t , cognate to T330, N332, V333, F337 in ? i2 (Figure 1), increased nucleotide exchange &lt;b&gt;rates&lt;/b&gt; [ 5 ] . Two of these critical amino acids, N332 and V333 in ? i2 , are in fact the first two amino acids that are replaced by the novel splicing in s? i2 (Figure 1)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="25002" end="25007" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="The data in this report are consistent with a scenario in which intracellular Golgi/ER localization of s? i2 reflects its &lt;b&gt;rapid&lt;/b&gt; degradation rather than specific targeting to a subcellular organelle." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="31916" end="31921" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Instead, it is tempting to speculate that alternative splicing may be a mechanism to regulate cellular levels of ? i2 . In this model, certain conditions may favor the formation of s? i2 compared to ? i2 , and the resulting &lt;b&gt;rapid&lt;/b&gt; degradation of s? i2 would decrease the cellular content of ? i2 . A precedent for such alternative splicing-dependent regulation of expression has been described for H-ras [ 34 ] . Alternative splicing occurs in H-ras, and the alternative spliced form is predicted to encode an unstable transcript and a protein product that lacks the ability to oncogenically transform cells." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="25002" end="25007" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="The data in this report are consistent with a scenario in which intracellular Golgi/ER localization of s? i2 reflects its &lt;b&gt;rapid&lt;/b&gt; degradation rather than specific targeting to a subcellular organelle." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="26880" end="26885" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Similarly, a recent report showed that the s? i2 35 amino acids were unable to retain a secreted protein in intracellular membranes and did not affect localization of a nuclear protein [ 4 ] . However, in addition to causing &lt;b&gt;rapid&lt;/b&gt; degradation, one cannot rule out that the 35 amino acid sequence of s? i2 functions somehow as part of a Golgi targeting motif in the context of other regions of ? i2 , as suggested [ 4 ] . Other researchers have described a specific Golgi membrane localization of s? i2 [ 4 ] ; in contrast, the results presented in this report always show a much more disperse subcellular localization of s? i2 to intracellular membranes consistent with staining of both Golgi and ER." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="31916" end="31921" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Instead, it is tempting to speculate that alternative splicing may be a mechanism to regulate cellular levels of ? i2 . In this model, certain conditions may favor the formation of s? i2 compared to ? i2 , and the resulting &lt;b&gt;rapid&lt;/b&gt; degradation of s? i2 would decrease the cellular content of ? i2 . A precedent for such alternative splicing-dependent regulation of expression has been described for H-ras [ 34 ] . Alternative splicing occurs in H-ras, and the alternative spliced form is predicted to encode an unstable transcript and a protein product that lacks the ability to oncogenically transform cells." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="25002" end="25007" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="The data in this report are consistent with a scenario in which intracellular Golgi/ER localization of s? i2 reflects its &lt;b&gt;rapid&lt;/b&gt; degradation rather than specific targeting to a subcellular organelle." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="25002" end="25007" sStart="null" offset="0" sid="null" wn="2147483644" wnkey="null" text="The data in this report are consistent with a scenario in which intracellular Golgi/ER localization of s? i2 reflects its &lt;b&gt;rapid&lt;/b&gt; degradation rather than specific targeting to a subcellular organelle." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="15157" end="15162" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="This alanine to serine mutation in the C-terminal region of ? i1 (A326S) and ? s (A366S) has been shown to greatly accelerate GDP release, to accelerate irreversible inactivation in vitro , and to cause &lt;b&gt;rapid&lt;/b&gt; turnover of the ? subunit in cultured cells [ 9 10 ] . Thus, if the observed intracellular localization of s? i2 is caused by instability of the protein due to disruptions at its C-terminus, then it follows that ? i2 A327S should show a similar pattern of localization." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="23101" end="23106" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="The A326S mutation of ? i1 and A366S mutation of ? s (cognate to the ? i2 A327S used in this study) were shown to cause greatly decreased affinity for GDP [ 9 10 ] . Defective binding of GDP leads to more G? in the empty state (no bound guanine-nucleotide), and this form of G? is rapidly denatured in vitro , as shown for ? s A366S and ? i1 A326S [ 9 10 ] . Moreover, ? s A366S was demonstrated to undergo &lt;b&gt;rapid&lt;/b&gt; degradation (t 1/2 &lt; 1 h) in stably transfected cells [ 9 ] . The same mutation in ? t has also been shown to greatly decrease guanine-nucleotide binding [ 5 22 ] . Additional amino acids in the critical ?6-?5 loop are important for maintaining G? integrity [ 7 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="19882" end="19887" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="The inability to isolate cells stably expressing s? i2 can be attributed to its &lt;b&gt;rapid&lt;/b&gt; degradation." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="25002" end="25007" sStart="null" offset="0" sid="null" wn="2" wnkey="rapid%5:00:02:fast:01" text="The data in this report are consistent with a scenario in which intracellular Golgi/ER localization of s? i2 reflects its &lt;b&gt;rapid&lt;/b&gt; degradation rather than specific targeting to a subcellular organelle." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="25002" end="25007" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="The data in this report are consistent with a scenario in which intracellular Golgi/ER localization of s? i2 reflects its &lt;b&gt;rapid&lt;/b&gt; degradation rather than specific targeting to a subcellular organelle." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="26880" end="26885" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Similarly, a recent report showed that the s? i2 35 amino acids were unable to retain a secreted protein in intracellular membranes and did not affect localization of a nuclear protein [ 4 ] . However, in addition to causing &lt;b&gt;rapid&lt;/b&gt; degradation, one cannot rule out that the 35 amino acid sequence of s? i2 functions somehow as part of a Golgi targeting motif in the context of other regions of ? i2 , as suggested [ 4 ] . Other researchers have described a specific Golgi membrane localization of s? i2 [ 4 ] ; in contrast, the results presented in this report always show a much more disperse subcellular localization of s? i2 to intracellular membranes consistent with staining of both Golgi and ER." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-12.anc" start="4376" end="4386" sStart="null" offset="3" sid="r10.particular.j.0443" wn="2147483647" wnkey="null" text="In particular, attempts to detect endogenous s? i2 by immunofluorescence failed due to faint detection that showed drastically different patterns of staining depending upon fixation technique." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-12.anc" start="41773" end="41779" sStart="null" offset="116" sid="r9.normal.j.0184" wn="1" wnkey="normal%3:00:01::" text="After the 10 min pulse labeling, cells were either immediately lysed (see below) or washed with normal growth media and then &quot;chased&quot; by incubation in normal growth media for the indicated times." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="18878" end="18882" sStart="null" offset="0" sid="null" wn="1" wnkey="lose%2:40:02::" text="Immunoprecipitation of the ? subunit after increasing times of chase, followed by SDS-PAGE and fluorography revealed that radiolabeled s? i2 was rapidly &lt;b&gt;lost&lt;/b&gt;." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-12.anc" start="39267" end="39273" sStart="null" offset="52" sid="r9.level.n.0199" wn="1" wnkey="level%1:07:00::" text="Only cells displaying low to intermediate levels of expression were utilized." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-12.anc" start="11888" end="11894" sStart="null" offset="367" sid="r9.level.n.0964" wn="2" wnkey="level%1:26:01::" text="Accordingly, the myristoylation results (Figure 6Aand 6B, lanes 5 and 6) strongly suggested that ? i2 and s? i2 are translated equally well, as evidenced by similar levels of radiolabeled myristate incorporation during the labeling period, but s? i2 is more rapidly degraded, as seen by reduced steady-state levels of immunoprecipitated protein." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-3-12.anc" start="39313" end="39319" sStart="null" offset="0" sid="null" wn="3" wnkey="image%1:06:00::" text="&lt;b&gt;Images&lt;/b&gt; were processed with Adobe Photoshop." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-12.anc" start="30973" end="30977" sStart="null" offset="91" sid="r10.help.v.0604" wn="3" wnkey="help%2:42:00::" text="On the other hand, unknown protein(s) may function to stabilize s? i2 and help direct it to Golgi membranes." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-12.anc" start="31437" end="31446" sStart="null" offset="35" sid="r11.function.n.0560" wn="2147483645" wnkey="null" text="It is possible that s? i2 functions as a short-lived protein regulating some aspect of membrane transport pathways; however, no experiments to directly support or refute this hypothesis have been reported." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-12.anc" start="26331" end="26339" sStart="null" offset="91" sid="r11.function.n.0195" wn="2" wnkey="function%1:07:00::" text="The data presented here argue against a sequence specific Golgi membrane targeting function for the novel 35 amino acid sequence found in s? i2 . The novel sequence of s? i2 is not sufficient to direct other proteins to Golgi/ER membranes." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-12.anc" start="31027" end="31038" sStart="null" offset="11" sid="r11.combination.n.0173" wn="1" wnkey="combination%1:14:00::" text="A specific combination of ? and ? subtypes may play such a role; however, one thorough study showed a lack of ?? on Golgi membranes of exocrine pancreatic cells even though a variety of G? were readily detected in the Golgi [ 33 ] . Other proteins that may specifically promote the intracellular targeting of G? have not been identified." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-12.anc" start="29317" end="29324" sStart="null" offset="200" sid="r9.appear.v.0386" wn="1" wnkey="appear%2:39:00::" text="s? i2 may exist in a state that does not interact well with ?? simply because it is in the process of being irreversibly inactivated [ 9 10 ] . Similarly, ? i2 A327S appears not to be defective in its intrinsic ability to interact ?? [ 10 ] , and co-expression of ?? shifts ? i2 A327S, like s? i2 , from intracellular to plasma membranes (Figure 8)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-3-12.anc" start="14067" end="14074" sStart="null" offset="175" sid="r11.absence.n.0786" wn="1" wnkey="absence%1:26:00::" text="In fact, the localization pattern of ? i2 after 4 h incubation with ALLN (Figure 7E) is similar to the observed localization of s? i2 in the absence or presence of ALLN treatment (Figure 7B, 7D, and 7F)." />
  </sentences>
</list>